INAB

IN8BIO INC

INAB·45674E208·US·Common Stock·Healthcare - Biotechnology-Activist

INAB (IN8BIO INC) is held by 11 institutional investors as of Q1 2026. Largest holders: Alyeska Investment Group, L.P. ($1.4M), FRANKLIN RESOURCES INC ($1.4M), GEODE CAPITAL MANAGEMENT, LLC ($127,635). Net institutional sentiment: Bearish.

11
Holders
Avg rating(2 Elite)
$3M
Total Value
27% (15)
Fund Consensus
3 buying - 8 selling
INABSmart Money Verdict
View all
Held by 11 funds
2 elite
Who's Trading
ActivistEFEMILY FAIRBAIRN2.2%May 29, 2026
ActivistLLLYTTON LAURENCE W10.0%Mar 2, 2026
ActivistAIAlyeska Investment Group, L.P.9.9%Feb 17, 2026
ActivistFranklin Resources, Inc.Franklin Resources, Inc.9.4%Jan 29, 2026
ActivistEFEMILY FAIRBAIRN7.5%Jan 2, 2026
Activist68683 Capital Management, LLC7.9%Dec 30, 2025
ActivistBIBIOS Fund II, LP0.2%Dec 29, 2025
ActivistSTStonepine Capital Management, LLC9.9%Dec 22, 2025
ActivistAIAlyeska Investment Group, L.P.2.6%Aug 14, 2025
ActivistWTWilliam Tai-Wei Ho3.7%Aug 13, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
944,319(-1.4%)$1.4M0.0%-56.18%
0
Unchanged
914,531$1.4M0.0%-62.24%
0
Increased
86,239(+311.3%)$127,6350.0%-82.08%
24
Increased
33,295(+82.0%)$49,2770.0%-35.29%
32
Increased
20,440(+17.5%)$30,2510.0%-40.61%
16
Decreased
12,433(-27.1%)$18,4010.0%-41.63%
0
Unchanged
2,785$4,1220.0%-77.38%
0
Decreased
768(-37.5%)$1,0830.0%-42.92%
0
Decreased
480(-38.2%)$7100.0%-45.61%
0
Unchanged
84$1240.0%-83.52%
0
Unchanged
83$1230.0%-41.15%
0
Exited
0(-100.0%)$870.0%-71.13%
0
Exited
0(-100.0%)$800.0%-26.18%
0
Exited
0(-100.0%)$66,0210.0%-23.89%
0
Exited
0(-100.0%)$34,0000.0%-26.18%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used